Differential decline of SARS‐CoV‐2‐specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID‐19

Bernhard Kratzer; Pia Gattinger; Doris Trapin; Paul Ettel; Ulrike Körmöczi; Arno Rottal; Robert B. Stieger; Al Nasar Ahmed Sehgal; Melanie Feichter; Kristina Borochova; Inna Tulaeva; Katharina Grabmeier‐Pfistershammer; Peter A. Tauber; Thomas Perkmann; Ingrid Faé; Sabine Wenda; Michael Kundi; Gottfried Fischer; Rudolf Valenta; Winfried F. Pickl

doi:10.1111/all.16210

Abstract

SARS-CoV-2 has triggered a pandemic and contributes to long-lasting morbidity. Several studies have investigated immediate cellular and humoral immune responses during acute infection. However, little is known about long-term effects of COVID-19 on the immune system.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kratzer et al. (2024) studied this question.

synapsesocial.com/papers/68e6055db6db643587599206 https://doi.org/10.1111/all.16210

View Full Paper

Ask AI

Bookmark

Share

Differential decline of SARS‐CoV‐2‐specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID‐19

Abstract

Discussion

Cite This Study

Differential decline of SARS‐CoV‐2‐specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID‐19

Abstract

Discussion

Cite This Study

Keep reading

Keep reading